Summary of Study ST001925

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001215. The data can be accessed directly via it's Project DOI: 10.21228/M8NQ5X This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001925
Study TitleMS Untargeted Metabolomics from Human Serum
Study SummaryMultiple Myeloma patients were treated with the proteasome inhibitor carfilzomib in different protocols according to their clinical stage. Paired serum samples were obtained before i.v injection and after 1-8h post treatment and snap frozen. Samples were stored at -80°C until analysis.
Institute
University of Zurich
Last NameMendez
First NameMax
AddressRorschacherstrasse 95. 9007, St.Gallen
Emailmaxmendez@runbox.com
Phone+41 71 494 10 67
Submit Date2021-09-21
Num Groups2
Total Subjects6
Num Males5
Num Females1
Raw Data AvailableYes
Raw Data File Type(s)raw(Waters)
Analysis Type DetailLC-MS
Release Date2022-01-02
Release Version1
Max Mendez Max Mendez
https://dx.doi.org/10.21228/M8NQ5X
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id class
SA178102Post1_NEGPOSTREATMENT
SA178103Post1_POSPOSTREATMENT
SA178104Post5_NEGPOSTREATMENT
SA178105Post6_POSPOSTREATMENT
SA178106Post3_NEGPOSTREATMENT
SA178107Post3_POSPOSTREATMENT
SA178108Post5_POSPOSTREATMENT
SA178109Post6_NEGPOSTREATMENT
SA178110Post2_POSPOSTREATMENT
SA178111Post4_POSPOSTREATMENT
SA178112Post2_NEGPOSTREATMENT
SA178113Post4_NEGPOSTREATMENT
SA178114Pre4_POSPRETREATMENT
SA178115Pre5_POSPRETREATMENT
SA178116Pre1_POSPRETREATMENT
SA178117Pre2_POSPRETREATMENT
SA178118Pre3_POSPRETREATMENT
SA178119Pre6_POSPRETREATMENT
SA178120Pre2_NEGPRETREATMENT
SA178121Pre1_NEGPRETREATMENT
SA178122Pre6_NEGPRETREATMENT
SA178123Pre3_NEGPRETREATMENT
SA178124Pre4_NEGPRETREATMENT
SA178125Pre5_NEGPRETREATMENT
SA178126QC_14_POSQC
SA178127QC_13_POSQC
SA178128QC_11_POSQC
SA178129QC_12_POSQC
SA178130QC_06_POSQC
SA178131QC_10_NEGQC
SA178132QC_11_NEGQC
SA178133QC_09_NEGQC
SA178134QC_08_NEGQC
SA178135QC_07_NEGQC
SA178136QC_12_NEGQC
SA178137QC_13_NEGQC
SA178138QC_08_POSQC
SA178139QC_09_POSQC
SA178140QC_07_POSQC
SA178141QC_06_NEGQC
SA178142QC_14_NEGQC
SA178143QC_10_POSQC
Showing results 1 to 42 of 42
  logo